Inventor · disambiguated record
Martin E. Gleave
Also filed as: GLEAVE MARTIN · GLEAVE MARTIN E
54 granted patents·14 pending applications·366 citations·filing 2000–2024
98Inventor score
Top patents by PatentIndex Score
68 records- 0198US7732422B2TRPM-2 antisense therapyUNIV BRITISH COLUMBIA·Filed 2007·Granted Jun 8, 2010·125 cites·5 claims
- 0293US7973017B2Treatment of cancer by inhibition of IGFBP's and clusterinUNIV BRITISH COLUMBIA·Filed 2005·Granted Jul 5, 2011·9 cites·21 claims
- 0393US6900187B2TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modificationsUNIV BRITISH COLUMBIA·Filed 2002·Granted May 31, 2005·37 cites·11 claims
- 0492US8470796B2Treatment of cancer by inhibition of IGFBPs and clusterinGLEAVE MARTIN E·Filed 2011·Granted Jun 25, 2013·6 cites·10 claims
- 0592US7592323B1TRPM-2 antisense therapyUNIV BRITISH COLUMBIA·Filed 2006·Granted Sep 22, 2009·14 cites·11 claims
- 0692US7368436B2TRPM-2 antisense therapyUNIV BRITISH COLUMBIA·Filed 2001·Granted May 6, 2008·35 cites·8 claims
- 0791US8541390B2Treatment of cancer by inhibition of IGFBPs and clusterinGLEAVE MARTIN E·Filed 2012·Granted Sep 24, 2013·4 cites·1 claims
- 0890US9095602B2Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotidesGLEAVE MARTIN·Filed 2013·Granted Aug 4, 2015·7 cites·12 claims
- 0988US8361981B2Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotidesUNIV BRITISH COLUMBIA·Filed 2009·Granted Jan 29, 2013·4 cites·14 claims
- 1088US8252765B2Treatment of cancer by inhibition of IGFBPs and clusterinGLEAVE MARTIN E·Filed 2011·Granted Aug 28, 2012·6 cites·5 claims
- 1188US7723312B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2005·Granted May 25, 2010·3 cites·8 claims
- 1288US7285541B2Treatment of melanoma by reduction in clusterin levelsUNIV BRITISH COLUMBIA·Filed 2003·Granted Oct 23, 2007·18 cites·12 claims
- 1387US8173615B2TRPM-2 antisense therapyGLEAVE MARTIN·Filed 2010·Granted May 8, 2012·7 cites·4 claims
- 1487US7101991B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2003·Granted Sep 5, 2006·11 cites·9 claims
- 1586US7928082B2Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using sameUNIV BRITISH COLUMBIA·Filed 2008·Granted Apr 19, 2011·3 cites·5 claims
- 1686US7550580B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2006·Granted Jun 23, 2009·2 cites·6 claims
- 1784US8389491B2Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using sameGLEAVE MARTIN·Filed 2010·Granted Mar 5, 2013·2 cites·8 claims
- 1883US9580712B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2016·Granted Feb 28, 2017·1 cites·12 claims
- 1983US7534773B1TRPM-2 antisense therapyUNIV BRITISH COLUMBIA·Filed 2000·Granted May 19, 2009·11 cites·12 claims
- 2082US8710020B2Clusterin antisense therapy for treatment of cancerGLEAVE MARTIN E·Filed 2005·Granted Apr 29, 2014·3 cites·32 claims
- 2182US8536149B2TRPM-2 antisense therapyGLEAVE MARTIN·Filed 2012·Granted Sep 17, 2013·3 cites·20 claims
- 2282US7196067B2Antisense insulin-like growth factor binding protein (IGFBP)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapyUNIV BRITISH COLUMBIA·Filed 2001·Granted Mar 27, 2007·13 cites·8 claims
- 2381US7569551B2Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotidesUNIV BRITISH COLUMBIA·Filed 2001·Granted Aug 4, 2009·13 cites·42 claims
- 2480US9101646B2Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using sameGLEAVE MARTIN·Filed 2010·Granted Aug 11, 2015·1 cites·9 claims
- 2578US9200285B2Clusterin antisense therapy for treatment of cancerUNIV BRITISH COLUMBIA·Filed 2014·Granted Dec 1, 2015·2 cites·20 claims
- 2678US8772470B1Compositions and methods for treatment of prostate and other cancersGLEAVE MARTIN·Filed 2007·Granted Jul 8, 2014·1 cites·27 claims
- 2778US7847091B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2009·Granted Dec 7, 2010·0 cites·18 claims
- 2878US7820635B2RNAi probes targeting cancer-related proteinsUNIV BRITISH COLUMBIA·Filed 2008·Granted Oct 26, 2010·2 cites·4 claims
- 2977US9205102B2Method for treatment of castration-resistant prostate cancerUNIV BRITISH COLUMBIA·Filed 2014·Granted Dec 8, 2015·2 cites·24 claims
- 3076US11167034B2Polymeric paste compositions for drug deliveryUNIV BRITISH COLUMBIA·Filed 2018·Granted Nov 9, 2021·1 cites·18 claims
- 3175US9074209B2TRPM-2 antisense therapyGLEAVE MARTIN·Filed 2013·Granted Jul 7, 2015·1 cites·20 claims
- 3274US9186410B2Derivatized hyperbranched polyglycerolsBURT HELEN·Filed 2011·Granted Nov 17, 2015·4 cites·42 claims
- 3374US9085769B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2014·Granted Jul 21, 2015·0 cites·19 claims
- 3473US7297684B1Antisense therapy for hormone-regulated tumorsUNIV BRITISH COLUMBIA·Filed 2000·Granted Nov 20, 2007·6 cites·29 claims
- 3571US9561278B2Derivatized hyperbranched polyglycerolsUNIV BRITISH COLUMBIA·Filed 2015·Granted Feb 7, 2017·1 cites·38 claims
- 3671US2025205340A1Mucoadhesive Polymeric Drug Delivery Compositions and MethodsUNIV BRITISH COLUMBIA·Filed 2024·Application pending·0 cites
- 3770US12378301B2B1SP fusion protein therapeutics, methods, and usesUNIV BRITISH COLUMBIA·Filed 2021·Granted Aug 5, 2025·0 cites·7 claims
- 3870US7932234B2Bispecific oligonucleotide for the treatment of CNS malignanciesUNIV BRITISH COLUMBIA·Filed 2005·Granted Apr 26, 2011·2 cites·23 claims
- 3969US8580761B2Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using sameUNIV BRITISH COLUMBIA·Filed 2012·Granted Nov 12, 2013·0 cites·8 claims
- 4068US8808693B2Semaphorin 3C (Sema3C) inhibitor therapeutics, methods, and usesONG CHRISTOPHER J·Filed 2010·Granted Aug 19, 2014·2 cites·15 claims
- 4167US8835401B2Treatment of cancer by inhibition of IGFBPs and clusterinUNIV BRITISH COLUMBIA·Filed 2013·Granted Sep 16, 2014·0 cites·15 claims
- 4267US8168610B2Bispecific oligonucleotide for the treatment of CNS malignanciesGLEAVE MARTIN·Filed 2011·Granted May 1, 2012·2 cites·2 claims
- 4366US2016002630A1Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using SameUNIV BRITISH COLUMBIA·Filed 2015·Application pending·0 cites
- 4466US2003158143A1Bispecific antisense olignucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using sameFiled 2003·Application pending·0 cites
- 4565US9404109B2Compositions and methods for treatment of prostate and other cancersUNIV BRITISH COLUMBIA·Filed 2015·Granted Aug 2, 2016·0 cites·29 claims
- 4663US8252918B2RNAi probes targeting cancer-related proteinsGLEAVE MARTIN E·Filed 2003·Granted Aug 28, 2012·1 cites·4 claims
- 4762US10525131B2Derivatized hyperbranched polyglycerolsUNIV BRITISH COLUMBIA·Filed 2018·Granted Jan 7, 2020·0 cites·70 claims
- 4862US9457045B2Combination of anti-clusterin oligonucleotide with Hsp90 inhibitor for the treatment of prostate cancerGLEAVE MARTIN E·Filed 2012·Granted Oct 4, 2016·1 cites·15 claims
- 4961US12171833B2Mucoadhesive polymeric drug delivery compositions and methodsUNIV BRITISH COLUMBIA·Filed 2021·Granted Dec 24, 2024·0 cites·20 claims
- 5059US7964717B2RNAi probes targeting cancer-related proteinsUNIV BRITISH COLUMBIA·Filed 2006·Granted Jun 21, 2011·0 cites·21 claims
Showing the top 50 of 68 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →